Between 2005 and 2007, the recommended vaccination schedule for adolescents expanded to include vaccines to protect against pertussis, meningitis (MCV4), and for girls, human papillomavirus (HPV).1-3 The most recent data available from the 2009 National Immunization Survey-Teen show that, while coverage among 13- to 17-year-old adolescents has been increasing for each of these vaccines, it remains suboptimal: 55.6% received pertussis, 53.6% received MCV4, and 26.7% (females only) received all 3 doses of the HPV vaccine series.4 Evidenced-based strategies to increase vaccination coverage among adolescents are needed.
Stokley S, Vogt T, Shefer A. Increasing Adolescent Vaccination Coverage: The Challenges That Remain. Arch Pediatr Adolesc Med. 2011;165(6):568–570. doi:10.1001/archpediatrics.2011.65
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: